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DtralG inflammation an influx of neutrophils
and release of mediators from mast cells (such as
histamine) take place. The stimulated neutrophils
can produce reactive oxygen species (ROS). One
of these ROS is the highly reactive hydroxyl
radical (OH’). It would be interesting to be able to
quantify the extent of ROS formation. We investi-
gated if histamine which is present at the inflam-
mation sRe can serve as an endogenous marker
for the formation of OH’. We found that hista-
mine after incubation with OH" gave two distinct
products in our HPLC system. One of the
products gave the same characteristics as the syn-
thesized 2-imidazolone derivative of histamine.
This suggests that this derivative will be formed
when histamine is incubated with OH’.
Key words: Histamine, Hydroxyl radicals, Marker, Product
characterization.
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Introduction
Neutrophils are the most prominent migratory
cdlular elements in most forms of acute inflam-
mation, particularly during the initial .stages.
These cells will kill and digest bacteria at the
inflammation site (phagocytosis). Activation of
neutrophils includes a stimulation of the mem-
brane bound enzyme, NADPH oxidase. This
enzyme is responsible for the one-electron
reduction of molecular oxygen to a superoxide
anion radical. Subsequent reactions lead to the
formation of other reactive oxygen species (ROS)
such as hydrogen peroxide (H202) hypo-
chlorous acid (HOCl) and hydroxyl radicals
(OH’).1-3 These ROS can cause injury to cells
and tissues. In several pathological processes
such as myocardial injury and lung diseases ROS
4 7are thought to be involved.
Basophil leukocytes and tissue mast cells are
inflammatory cells that are found in virtually all
human tissues. These cells can release a variety
of chemical mediators, including histamine, upon
appropriate stimulation.8 Studies have shown that
ROS released extracellularly from phagocytosing
neutrophils at an inflammation site can cause
degranulation and histamine release from mast
cells.9-11 In vivo acetylsalicylic acid had been
suggested as a marker for OH" formation.2 This
study was undertaken to investigate whether his-
tamine could serve as an OH" marker. The
advantage of histamine is that it is already
present at the site of inflammation and no exo-
genous compounds have to be administered.
Materials and Methods
Chemicals: Histamine, hydantoin-5-acetic acid and
DL-aspartic acid were obtained from Sigma Che-
mical Co. (St Louis, USA). Hydrogen peroxide,
EDTA and t-ascorbic acid were purchased from
J.T. Baker Chemicals B.V. (Deventer, The Nether-
lands). FeCl3 and CuSO4 were supplied by E.
Merck (Darmstadt, Germany). Sodium dodecyl
sulphate (SDS, ultrapure) was obtained from
USB (Cleveland, USA). Sodium octyl sulphonate
(SOS) was purchased from Kodak (Rochester
NY, USA) and ophtalaldehyde (OPA) was
obtained from Janssen Chimica (Geel, Belgium).
All other chemicals were of analytical grade and
used without additional purification.
High-performance liquid chromatography: The
HPLC system consisted of a Gilson 305 pump, a
Gilson 232/401 autoinjector and a Gilson 117 UV
detector obtained from Meyvis Co. (Bergen op
Zoom, The Netherlands), with a reversed phase
C8 column, 100 x 3 mm I.D., 5 t.tm particles pur-
chased from Chrompack (Middelburg, The Neth-
erlands). The injection volume was 50 tl and the
flowrate was 0.5 ml/min. The samples were mon-
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itored spectrophotometrically at 210nm. The
mobile phase was 10mM KH2PO4 (pH 7.0)
MeOH (60:40, v/v) containing 3 mM SDS.
Incubations with OH’: The OH" were generated
via three different incubation conditions. The first
system contained 100M FeC13, 100 I.tM EDTA,
1001.tM ascorbic acid and I mM H202 inphos-phate buffer (20mM KHiPO4, pH 7.0). The
second system contained 5 mM ascorbic acid and
0.05 mM CuSO4 in the phosphate buffer14 and the
third system contained 50mM H202 and 0.5 mM
CuSO4 in the phosphate buffer.5 In all of these
OH" generating systems histamine (2.7 mM)was
added for a period of time at 37C. The reaction
mixtures were injected directly on the column.
OPA-derivatization: Histamine, the synthesized
2-imidazolone derivative of histamine and the
collected samples from the above mentioned
HPLC system were post-column derivatized with
OPA by a continuous flow reaction system
according to Yamotodani16 with some modifica-
tions. The samples were injected on a reversed
phase C8 column and were eluted with 0.16M
KI-I2PO4 containing 0.5 mM SOS at a flow rate of
0.6ml/min. The eluate from the column was
mixed first with 0.1% OPA solution at a flow
rate of 0.12ml/min, subsequently 2.5M NaOH
was added (0.12ml/min). The solution was
mixed in a reaction coil made of poly-
etheretherketone tubing (8m x 0.5mm I.D.),
obtained from Bester (Amstelveen, The Nether-
lands) and thermostated at 50C, and then 1 M
HNO3 was added (0.2ml/min). The pH of the
final reaction mixture was 2.5. The fluorescence
intensity was measured at 450 nm with excitation
at 350nm by a Hewlett Packard 1046 Program-
mable Fluorescence Detector.
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FIG. 1. The reaction scheme for the synthesis of the 2-imidazo-
lone derivative of histamine.
NMR (D20); 8 2.80 (t, 2H, -CH2), 3.15 (t, 2H,
(-CH2), 6.35 (s, 1H, ring-H), same results were
found by Keller et al.8 This compound gave a
peak at 6.0 min in our HPLC system (data not
shown).
In this study we were interested in the product
formation of histamine in the presence of OH’.
Histamine, dissolved in phosphate buffer, eluted
at 10.6 min in our HPLC system (data not
shown). When histamine was incubated with a
OH" generating system like FeCI, EDTA, ascor-
bate and H202 for 3h at 37C, peaks at the
retention times of 6.0 and 7.6 min appeared next
Synthesis of the 2-imidazolone derivative of his-
tamine: The 2-imidazolone derivative of hista-
mine was synthesized according to the method
of kerfield and Dahlenv (Fig. 1). Histamine was
hydrolysed to 1,4 diamino-buta-2-one. Condensa-
tion of the diamine ketone with potassium
cyanate gave the 2-imidazolone derivative which
was isolated as its hydrochloride salt. The 2-imi-
dazolone derivative of histamine was character-
ized by H-NMR.
Results
The synthesized 2-imidazolone derivative (see
Materials and Methods) shown to be identical to
the material reported by kerfield;17 m.p. 226-
230C (dec) (.kerfield found 227-230C). 1H-
3
2
Time (min)
FIG. 2. Typical reversed-phase chromatogram of incubation
samples of histamine (2.7mM) with 1001M FeCI3, 1001M
EDTA, 100tM ascorbic acid and mM H202. This sample was
incubated for 3 h at 37C and revealed products at 6.0 (peak 1)
and 7.6 min (peak 2) next to histamine which eluted at 10.2
min (peak 3). The paxis represents the absorbance intensity
(arbitrary units), the x-axis represents the retention time (min).
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to the histamine peak at 10.2 min (Fig. 2). In the
literature other OH" generating systems have
been reported such as ascorbate/Cu2+ according
to Uchida4 and a system containing H202/
Cu2+.5 When histamine was incubated with
ascorbate/Cu2+ for 5h at 37C again two fairly
separated peaks appeared at 6.2 and 7.6 min and
histamine was found at 10.9 min (Fig. 3). When
histamine was incubated in the H202//Cu2+
system for 5 h at 37C, the reaction products in
the chromatogram appeared at 6.0 and 7.6 min
(Fig. 4). Surprisingly, histamine was not seen in
the chromatogram in this system. A possible
explanation for this could be that all the hista-
mine might be complexed by the metal ion
Cu2 +. However, a simple complexation of Cu2+
and histamine could not explain this as the
absorbance of histamine (at 210nm) remained
unchanged after an incubation of histamine and
Cu2+. Another small absorbance maximum
appeared at 256nm in the presence of Cu+
(F g. 5).
After OPA derivatization of the synthesized 2-
imidazolone derivative of histamine the product
eluted at 4.4 min. The collected product (at 6.0
min) gave after OPA derivatization products at
4.4 and 7.2 min (Fig. 6). The product which
appeared at 7.2 min originates from histamine.
3
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FIG. 3. Typical reversed-phase chromatogram of incubation
samples of histamine (2.7mM) with 5mM ascorbic acid and
0.05 mM CuSO4. This sample was incubated for 5 h at 37C and
revealed products at 6.2 (peak 1) and 7.6 min (peak 2) next to
histamine (10.9 min, peak 3). The ]axis represents the absor-
bance intensity (arbitrary units), the x-axis represents the reten-
tion time (min).
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FIG. 5. An absorbance spectrum of histamine (0.135 mM) in the
presence of CuSO4 (0.025 mM) incubated for 24h at 37C. The
spectrum was obtained from 50gl of the incubation mixture
added to 950 gl eluent (used in the HPLC system).
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FIG. 4. Typical reversed-phase chromatogram of incubation
samples of histamine (2.7mM) with 50mM H202 and O.05mM
CuSO4. This sample was incubated for 5 h at 37C and revealed
products at 6.0 (peak 1) and 7.6 min (peak 2). No histamine
peak was observed. The y=axis represents the absorbance inten-
sity (arbitrary units), the x-axis represents the retention time
(min).
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FIG. 6. Typical chromatogram of the synthesized 2-imidazolone
derivative of histamine and the collected sample (at 6.0 min, see
Fig. 2) after OPA derivatization. The synthesized 2-imidazolone
derivative eluted at 4.4 min (A), the collected sample gave two
products, one at 4.4 min (B, peak 1) and the other at 7.2 min (B,
peak 2 histamine). The axis represents the fluorescence
intensity (arbitrary units), the x-axis represents the retention time
(min).
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Discussion mechanism had been proposed for the ascor-
bate/Cu2+ system. Here it was suggested that the
Histamine is a low-molecular weight biogenic histidine residue will complex with Cu2+. Then
amine and is involved in numerous physiological an electron will transfer from ascorbate to the
and pathophysiological processes including aller- Cu2 +-His complex, giving a Cu+-His complex.
gic reactions, vasodilatation and vasoconstrictions, This latter complex reacts subsequently with
gastric acid secretion, and neurotransmission.19 molecular oxygen to give an 02 adduct. It is
Histamine is formed by decarboxylation of the probable that the His-Cu+-O2 complex is fol-
amino acid histidine, this reaction is catalysed by lowed by generation of the His-Cu2+-O
the enzyme t-histidine decarboxylase. The major- complex. The authors now assume that the
ity of histamine in humans is stored in the gran- metal-peroxo complex like Cu+-O2 or Cu2+-
ules of circulating basophils and tissue mast ceils. O can react directly with the ligand (histidine
It is metabolized via two major pathways. In residue) itself, finally leading to the imidazolone
humans, histamine is primarily methylated to 1- product.25-28 However, in our study we were
methylhistamine by the enzyme histamine methyl- unable to find similar differences when histamine
transferase. This product is converted to 1-methyl- was incubated with the ascorbate/Cu2+ or the
imidazole-4-acetic acid by the enzyme mono- HiO2/Cu2+ system. Both situations revealed at
amine oxidase. In the other pathway, histamine is least two products with same retention times.
oxidized by diamine oxidase (histaminase) to These retention times of the products were iden-
imidazole-4-acetic acid (via imidazole-acet- tical with those found in the Fe+/HiOi/EDTA/
aldehyde), much of which is conjugated with ascorbate incubation, i.e. 6.0 and 7.6 min.
ribose and is excreted as the riboside.2’21 Results have been reported about the oxida-
Earlier studies have been conducted with the tion of histamine in the presence of ascorbate
compound imidazole and OH’. The radicals were and Cu2 +, in which the substrate histamine is
generated via pulse radiolysis of aqueous solu- completely broken down into aspartic acid.
tions of imidazole and it was found that OH" add Hydantoin-5-acetic acid had been identified as an
29 injec-at the C2 and C5 positions of the imidazole.22’2 intermediate in this conversion. When we
Samuni et al. even suggested an H abstraction ted aspartic acid or hydantoin-5-acetic acid on
from the NH of the imidazold, but this process our HPLC system retention times of 1.0 and 0.95
occurred only under basic conditions (pH 10- min were found respectively (data not shown).
12). The mechanism involved addition of the Although the incubations revealed a broader
OH" (at all pH values) and then the OH adduct band around 1 min (Figs 3 and 4), these com-
could undergo a base-catalysed water elimination pounds cannot explain the peaks found at 6.0
involving the OH and the H from NH.2 Uchida and 7.6 min. When we injected the synthesized 2-
et al.24 have tested a larger molecule which con- imidazolone derivative of histamine, a peak at 6.0
mined an imidazole, i.e. N-benzoylhistidine. The min was found (data not shown). This could
OH" were generated in an ascorbate/Cu2+ indicate that the product of 6.0 min might be the
system. Oxidation of the imidazole group was 2-imidazolone derivative of histamine. Similar
assumed to be initiated at the C2 position of the results were found for N-acetylhistamine incu-
imidazole group to yield an imidazolone deriva- bated in a ascorbate/Cu2+ system. The ascor-
five, N-benzoyl-J3-(2-oxo-imidazolonyl)alanine, as bate-mediated reaction was shown to occur
the main product. Other minor products were mainly at the imidazole group in histamine yield-
various ring-ruptured products and products ing a product that should have the structure of 4-
which were tentatively formed by the hydrogen [2-(acetylamino)ethyl]-2,3-dihydro imidazole-2-
abstraction of the z and 13 position of the sub- one. Another indication that suggests that the
strate. However, when another OH" generating product eluted at 6.0 min might be the 2-imida-
system such as H202/Cu2+ was used, the same zolone derivative of histamine, is that both the
ring-ruptured products were found. Surprisingly synthesized imidazolone derivative of histamine
the imidazolone derivative could not be detected and the isolated product at 6.0 min behave
in this system.5 The authors pointed to a serious similar in the OPA derivatization system (Fig. 6).
difference between the H202/Cu2+ and the We are aware that a definite characterization
ascorbate/Cu2+ system, as the data from the should be obtained with mass spectrometry,
HiO2/Cu2+ system were basically distinct from although the presence of SDS in the eluent was a
that of the ascorbate/Cu2+ system, major disturbing factor to obtaining a proper
In the H202/Cu2+ system an addition of the mass spectrum of the products. Histamine and
OH" was suggested to generate an imidazole probably also its derived products in OH" gen-
radical, followed by reaction with oxygen to give erating systems are relative small molecules and
ring-ruptured products.5 Another reaction quite difficult to identify with mass spectrometry
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as a relative high concentration of SDS is present.
The reason for this is that SDS will be fully frag-
rnented and in this way will disturb the low
molecular area of the mass spectrum. Even after
a purification by extraction of SDS the sample
was still not pure enough for mass spectrometry.
We have tried to use a cation-exchange column
in the HPLC system, but then instead of SDS the
rather high potassium phosphate concentration
disturbed the mass spectrum.
Functional experiments on the fight atria of
guinea-pigs revealed that the synthesized 2-imida-
zolone derivative of histamine showed no agonis-
tic or antagonistic activity on the H2 histamine
receptor (data not shown).
In summary, we found that histamine incu-
bated together with a OH" forming system gave
several products, one of which is probably the 2-
imidazolone derivative of histamine. This product
has a distinct retention time compared to the rest
of the products formed. This could mean that
biological compounds can be analysed for this 2-
imidazolone derivative in order to determine if
ROS such as OH" have been involved. The com-
pound histamine could then be an endogenous
marker for OH’. It has been reported that the
concentration of histamine, which will be
released at the site of an inflammation can be up
tO 10-3 M.2 The charm of using histamine as an
endogenous marker for OH’, above other bio-
markers discussed by Hageman et a/..3 is that
both OH" and histamine are released at the site
of the inflammation. The release of histamine can
even be stimulated by ROS. The involvement of
OH" in this pathological process might then be
indicated by the presence of the 2-imidazolone
derivative of histamine.
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